Skip to main content
Caplight Logo









Dr. Cash

Dr. Cash

Private
São PauloFinTechhttps://drcash.com.br/

Last Round

Series A

Dec 8, 2022

Est. Valuation

$33.36M

Total Funding Raised

$280,000

Company Overview

Dr. Cash operates in FinTech and is based in São Paulo. Its latest recorded funding round was a Series A round in December 2022.

Dr. Cash is a fintech company that provides an online financing platform for medical, aesthetic, and dental treatments.

Sector

FinTech

Verticals

Lending & Credit, BNPL, Digital Payments

Business Model

B2B2C

Customer Profile

Payment Processing Fee, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Dr. Cash Comparables

Compare Dr. Cash with similar companies based on industry and business-model similarity.

Dr. Cash comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Parcela Mais
88%
Capim
76%
Saúde Service
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Dr. Cash Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 8, 2022
SeedAug 25, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Lucas Hamú

CEO, Cofundador e Sócio

Executive Team

For institutional investors. Book with your work email.

Dr. Cash Investors

Notable investors and investment history

Dr. Cash investors
InvestorRounds
Bossa InvestSeed
SuperJobs Venture CapitalPre Seed
Incubate FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Monthly visitors increased 107% MoM, reaching 8.6K.

  • Aug 25, 2021

    $280K round led by Bossa Invest

Book a demo to see all signals

For institutional investors. Book with your work email.

Dr. Cash Filings

Explore SEC and related filing metadata, where available.

Dr. Cash filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Dr. Cash's valuation, stock price, and market status.

Is Dr. Cash a public or private company?

Dr. Cash is a private company.

What is the current stock price of Dr. Cash?

Dr. Cash is a private company, so its shares have no public market price. Caplight tracks Dr. Cash's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Dr. Cash worth (valuation)?

Dr. Cash's valuation is estimated at $33.4M based on funding round data.

Can I buy Dr. Cash stock?

Dr. Cash shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Dr. Cash's last funding round?

Dr. Cash's most recent funding round was Series A on December 8, 2022.

Who are the main investors in Dr. Cash?

Key investors in Dr. Cash include Bossa Invest.

Will Dr. Cash IPO soon?

No public IPO plans have been announced for Dr. Cash.

How can I track Dr. Cash secondary market activity?

Caplight tracks bids, offers, and trades in Dr. Cash's shares on secondary markets.

Firmographic Details

HeadquartersSão Paulo
Employee Range25
Year Founded2019
Last FundingDec 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?